A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis

BACKGROUND: Treosulfan, an alkylating agent, has demonstrated activity in recurrent ovarian carcinoma. It is equieffective as oral (p.o.) and intravenous (i.v.) formulation. To explore the preference and compliance of elderly patients regarding p.o. or i.v. treosulfan for the treatment of relapsed o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mahner, Sven, Oskay-Özcelik, Gülten, Heidrich-Lorsbach, Elke, Fuxius, Stefan, Sommer, Harald, Klare, Peter, Belau, Antje, Ruhmland, Birgit, Heuser, Thomas, Kölbl, Heinz, Markmann, Susanne, Sehouli, Jalid
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2012
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397225/
https://ncbi.nlm.nih.gov/pubmed/22526159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-012-1221-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items